BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2228568)

  • 1. Alleviation of experimental cyclosporin A toxicity by substitution of fish muscle oil as drug vehicle.
    Craighead IB; Heys SD; Smart LM; Thomson AW; Whiting PH
    Immunopharmacology; 1990; 20(1):21-9. PubMed ID: 2228568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplantation; 1987 Feb; 43(2):271-4. PubMed ID: 3810835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of immunosuppression by substitution of fish oil for olive oil as a vehicle for cyclosporine.
    Kelley VE; Kirkman RL; Bastos M; Barrett LV; Strom TB
    Transplantation; 1989 Jul; 48(1):98-102. PubMed ID: 2665242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
    Schnabel FR; Wait RB; Kahng KU
    Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat.
    Whiting PH; Woo J; Adam BJ; Hasan NU; Davidson RJ; Thomson AW
    Transplantation; 1991 Aug; 52(2):203-8. PubMed ID: 1871790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.
    Whiting PH; Barnard N; Neilsch A; Simpson JG; Burke MD
    Br J Exp Pathol; 1987 Dec; 68(6):777-86. PubMed ID: 3426946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function in rats treated with cyclosporin following unilateral nephrectomy.
    Whiting PH; Duncan JI; Gavin MP; Heys SD; Simpson JG; Asfar SK; Thomson AW
    Br J Exp Pathol; 1985 Oct; 66(5):535-42. PubMed ID: 4063158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of eicosanoids in cyclosporine nephrotoxicity in the rat.
    Erman A; Chen-Gal B; Rosenfeld J
    Biochem Pharmacol; 1989 Jul; 38(13):2153-7. PubMed ID: 2735953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cyclosporin A (CsA) nephrotoxicity in the rat: the effect of calcium blockade with verapamil.
    Shaikh MG; Heys SD; Brown PA; Whiting PH
    Int J Exp Pathol; 1993 Aug; 74(4):389-96. PubMed ID: 8398812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of cyclosporine (CsA)-induced nephrotoxicity by gamma linolenic acid (GLA) and eicosapentaenoic acid (EPA) in Wistar rats.
    Morphake P; Bariety J; Darlametsos I; Tsipas G; Gkikas G; Hornysh A; Papanikolaou N
    Prostaglandins Leukot Essent Fatty Acids; 1994 Jan; 50(1):29-35. PubMed ID: 8146206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cyclosporin nephrotoxicity in the rat: effects on renal function and morphology.
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Nephrol Dial Transplant; 1988; 3(3):317-26. PubMed ID: 3140107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporine on plasma lipids and modification with dietary fish oil.
    Jevnikar AM; Petric R; Holub BJ; Philbrick DJ; Clark WF
    Transplantation; 1988 Nov; 46(5):722-5. PubMed ID: 3194939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1403-6. PubMed ID: 3824502
    [No Abstract]   [Full Text] [Related]  

  • 17. Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat.
    Adams KE; Brown PA; Heys SD; Whiting PH
    Biochem Pharmacol; 1993 Dec; 46(11):2104-8. PubMed ID: 8267661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis.
    Petric R; Freeman D; Wallace C; McDonald J; Stiller C; Keown P
    Transplantation; 1990 Oct; 50(4):558-63. PubMed ID: 2219273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1993 Mar; 45(6):1351-4. PubMed ID: 8466554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free amino acids during chronic cyclosporine A toxicity in intact and partially nephrectomized rats.
    Holmes EW; Kinzler GJ; Flanigan RC; Bermes EW
    Exp Mol Pathol; 1991 Aug; 55(1):83-96. PubMed ID: 1884771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.